Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.17 USD | +2.48% | -0.13% | -35.08% |
04-23 | Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32 | MT |
04-18 | AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management | CI |
Sales 2024 * | 461M 36.83B | Sales 2025 * | 526M 41.97B | Capitalization | 1.12B 89.51B |
---|---|---|---|---|---|
Net income 2024 * | -34M -2.72B | Net income 2025 * | -27M -2.16B | EV / Sales 2024 * | 2.3 x |
Net cash position 2024 * | 61.14M 4.88B | Net cash position 2025 * | 78.13M 6.24B | EV / Sales 2025 * | 1.98 x |
P/E ratio 2024 * |
-31.5
x | P/E ratio 2025 * |
-40.4
x | Employees | 1,200 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.92% |
Latest transcript on AtriCure, Inc.
1 day | +2.48% | ||
1 week | -0.13% | ||
Current month | -23.83% | ||
1 month | -23.83% | ||
3 months | -30.32% | ||
6 months | -30.50% | ||
Current year | -35.08% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Carrel
CEO | Chief Executive Officer | 53 | 01/11/12 |
Angela Wirick
DFI | Director of Finance/CFO | 46 | 30/06/14 |
Chief Tech/Sci/R&D Officer | 52 | 28/02/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Prange
BRD | Director/Board Member | 60 | 03/12/19 |
Michael Carrel
CEO | Chief Executive Officer | 53 | 01/11/12 |
Sven Wehrwein
BRD | Director/Board Member | 73 | 09/11/16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 509 M€ | -.--% | ||
0.03% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 23.17 | +2.48% | 380,567 |
25/04/24 | 22.61 | -1.91% | 326,849 |
24/04/24 | 23.05 | -0.52% | 419,955 |
23/04/24 | 23.17 | +2.03% | 947,750 |
22/04/24 | 22.71 | -2.11% | 684,150 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.08% | 1.12B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- ATRC Stock